Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-16

FDA Approved: GLYBURIDE — Supplemental Application (TEVA Pharmaceuticals USA Inc)

View source ↗

Summary

FDA approves TEVA Pharmaceuticals USA Inc's supplemental application for GLYBURIDE. The action updates the approved glyburide product through a supplemental NDA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)